Work

Faculty Opinions recommendation of Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

Year: 2010

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.3865957.4011054

Authors: Michael Deininger, Paul La Rosée

Institutions: University of Utah, Huntsman Cancer Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4229877857

Cites:

Cited by:

Related to: 10